Trump and Regeneron will unveil a drug pricing deal

President Donald Trump is set to announce a deal with Regeneron to lower drug costs as part of the White House's effort to lower drug prices.

The agreement includes lowering the prices of current and future drugs on Medicaid and selling a cholesterol drug for $225 on the White House's discounted drug website TrumpRx.

The deal first reported by NOTUS is part of the Trump administration's efforts to provide economic relief to Americans ahead of the midterm elections.

It's one of many deals that the White House has struck that aim to align U.S. pharmaceutical prices with other developed nations.

Details of these agreements remain undisclosed, but Health Secretary Robert F. Kennedy Jr. says non-proprietary information will be shared with Congress.